Jane Street Group, LLC Novo Nordisk A S Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $76.3 Million - $93.2 Million	640,600 New	640,600 $76.3 Million
Q1 2022 May 17, 2022	SELL	$93.1 - $112.54 $10 Million - $12.1 Million	-107,900 Reduced 37.54%	179,500 $19.9 Million
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $3.36 Million - $4.1 Million	-35,000 Reduced 10.86%	287,400 $32.2 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $21.2 Million - $26.8 Million	251,500 Added 354.72%	322,400 $31 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $3.33 Million - $4.17 Million	49,200 Added 226.73%	70,900 $5.94 Million
Q1 2021 May 18, 2021	SELL	$67.06 - $75.82 $3.11 Million - $3.52 Million	-46,400 Reduced 68.14%	21,700 $1.46 Million
Q4 2020 Feb 17, 2021	BUY	$63.89 - $73.8 $3.3 Million - $3.82 Million	51,700 Added 315.24%	68,100 $4.76 Million
Q3 2020 Nov 17, 2020	SELL	$63.69 - $70.22 $3.13 Million - $3.45 Million	-49,200 Reduced 75.0%	16,400 $1.14 Million
Q2 2020 Aug 17, 2020	BUY	$58.54 - $67.94 $3.1 Million - $3.6 Million	53,000 Added 420.63%	65,600 $4.3 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $44,514 - $58,302	900 Added 7.69%	12,600 $759,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $214,398 - $250,518	4,300 Added 58.11%	11,700 $677,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $209,176 - $235,092	-4,400 Reduced 37.29%	7,400 $383,000
Q2 2018 Aug 15, 2018	BUY	$44.29 - $50.42 $327,746 - $373,108	7,400 Added 168.18%	11,800 $544,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $181,060 - $216,568	4,400	4,400 $212,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.